Microsoft Research introduces Quine, a biology world model tested on pancreatic cancer

What Microsoft Research announced

Microsoft Research introduced Quine on 29 September 2026, in a post by vice president and distinguished scientist Nicolo Fusi and vice president Jonathan M. Carlson. Quine has two parts. The first is a multimodal world model of biology that learns shared representations across sequence, structure, function, cell state and imaging data, trained on genomics, proteins, chemistry, RNA and cell state, and bioimaging. The second is a harness that handles orchestration and reasoning and connects models, scientific tools, literature, the wet lab and researchers.

Microsoft calls Quine a first step towards a longer-term vision. It is experimental research technology, not intended for clinical or medical use, and the post says its outputs may be incomplete or inaccurate and need review by qualified researchers and experimental validation. The framing question in the post is "what would it take to build a world model for biology?"

The pancreatic cancer study

With the Broad Institute of MIT and Harvard, the team applied Quine to pancreatic ductal adenocarcinoma (PDAC) using patient-derived ex vivo models. Quine predicted and ranked thousands of compounds by their potential to move tumour cells from the classical to the basal state. In lab assays, the highest-ranked compounds produced the largest intended shifts, and some of the strongest effects came from compounds with unexpected mechanisms of action, which the authors suggest could point to drug repurposing.

The whole loop, from narrowing the search to validating a handful of candidates in the lab, took one weekend, which the authors say could save months. The reverse shift, from basal to classical, was harder: Quine predicted weaker effects for available compounds, and the experiments agreed. Quine also predicted that some compounds would push cells to a distinct third state, which the lab work supported.

Why it matters

Quine is pitched as a closed loop in which the model proposes, the lab tests and the results feed back. The authors are frank that "the world model doesn't need to be perfect" to be useful for designing experiments. The evidence so far comes from one cancer model and the post reports no benchmark scores, so it is a promising case study rather than a measured comparison. Google DeepMind's AlphaGenome Atlas, released three weeks earlier, takes the opposite route of publishing precomputed predictions for everyone.

What to watch next

Microsoft plans to add newly integrated RNA datasets to strengthen state-transition predictions and to provide calibrated confidence estimates. Applications for the first Quine Fellows cohort were open at launch, and the project site is on GitHub Pages. More AI for science stories are under AI Research.

Questions people ask

What is Microsoft Quine?

An experimental AI research system from Microsoft Research, announced on 29 September 2026, that combines a multimodal world model of biology with a harness linking models, tools, literature, the wet lab and researchers.

What did Quine find in pancreatic cancer?

Its highest-ranked compounds produced the largest intended shifts from classical to basal cell states in Broad Institute lab tests, and some effective compounds had unexpected mechanisms of action.

Can researchers use Quine?

Initially only through the Quine Fellows programme and select collaborations. Microsoft plans wider access through Microsoft Discovery.

Sources

1. Introducing Quine: An AI research system designed for the complexity of biology (Microsoft Research, 29 Sep 2026)